Supplementary Figure Legend from Small-Molecule Inhibitors of USP1 Target ID1 Degradation in Leukemic Cells

Helena Mistry,Grace Hsieh,Sara J. Buhrlage,Min Huang,Eunmi Park,Gregory D. Cuny,Ilene Galinsky,Richard Stone,Nathanael S. Gray,Alan D. D’Andrea,Kalindi Parmar

DOI: https://doi.org/10.1158/1535-7163.22497586

2023-01-01

Abstract:PDF - 90KB, Legends for Supplemental Figures 1 through 6.

What problem does this paper attempt to address?

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Rajat Bhattacharya,Xiang-Cang Ye,Rui Wang,Xia Ling,Madonna McManus,Fan,Delphine Boulbes,Lee M. Ellis

DOI: https://doi.org/10.1158/0008-5472.22407995.v1

2023-01-01

Abstract:Legends for Supplementary Figures S1-S12.
Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Junying Zeng,Sharad Sharma,Yong‐Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22503690

2023-01-01

Abstract:PDF - 71K, Legends for Supplementary Figures 1 through 5.
Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Xiaohui Fan,Randall J. Brezski,Hui Deng,Pooja Dhupkar,Yun Q. Shi,Anneliese Gonzalez,Songlin Zhang,Michael A. Rycyzyn,William R. Strohl,Robert E. Jordan,Ningyan Zhang,Zhiqiang An

DOI: https://doi.org/10.1158/1535-7163.22501711

2023-01-01

Abstract:Figure S1: IdeS expression in BT474 breast cancer cells Figure S2: Detection of MMPs in cancer cell lysates and culture supernatant Figure S3: scIgG-T was not in the SKBR-3 cell culture medium Figure S4: Detection of immune cells infiltration in mice by flow cytometry.
Supplementary Figure 3 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Lauren A. Byers,Jing Wang,Monique B. Nilsson,Junya Fujimoto,Pierre Saintigny,John S. Yordy,Uma Giri,Michael Peyton,You Hong Fan,Lixia Diao,Fatemeh Masrorpour,Li Shen,Wenbin Liu,Boris Duchemann,Praveen K. Tumula,Vikas Bhardwaj,James Welsh,Stephanie Weber,Bonnie S. Glisson,Neda Kalhor,Ignacio I. Wistuba,Luc Girard,Scott M. Lippman,Gordon B. Mills,Kevin R. Coombes,John N. Weinstein,John D. Minna,John V. Heymach

DOI: https://doi.org/10.1158/2159-8290.22528434.v1

2023-01-01

Abstract:PDF file, 81K, Effect of PARP inhibition in combination with standard chemotherapy.
Supplementary Figure 1 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Lauren Averett Byers,Jing Wang,Monique B. Nilsson,Junya Fujimoto,Pierre Saintigny,John Yordy,Uma Giri,Michael Peyton,You Hong Fan,Lixia Diao,Fatemeh Masrorpour,Li Shen,Wenbin Liu,Boris Duchemann,Praveen Tumula,Vikas Bhardwaj,James Welsh,Stephanie Weber,Bonnie S. Glisson,Neda Kalhor,Ignacio I. Wistuba,Luc Girard,Scott M. Lippman,Gordon B. Mills,Kevin R. Coombes,John N. Weinstein,John D. Minna,John V. Heymach

DOI: https://doi.org/10.1158/2159-8290.22528440.v1

2023-01-01

Abstract:PDF file, 125K, Western blot of total PARP1.
Supplementary Methods and Figure Legends from USP22 Deubiquitinates CD274 to Suppress Anticancer Immunity

Xing Huang,Qi Zhang,Yu Lou,Junli Wang,Xinyu Zhao,Lin Wang,Xiaozhen Zhang,Shanshan Li,Yulan Zhao,Qi Chen,Tingbo Liang,Xueli Bai

DOI: https://doi.org/10.1158/2326-6066.22542108

2023-01-01

Abstract:Supplementary Materials and Methods, and Supplementary Figure legends.
Supplementary Figure Legends from Pharmacologic Activation of PKM2 Slows Lung Tumor Xenograft Growth

K. Mark Parnell,Jason M. Foulks,Rebecca N. Nix,Adrianne Clifford,Jeremy Bullough,Bin Luo,Anna V. Senina,David Vollmer,Jihua Liu,Virgil McCarthy,Yong Xu,Michael Saunders,Xiaohui Liu,Scott Pearce,Kevin B. Wright,Marc O’Reilly,Michael V. McCullar,Koc-Kan Ho,Steven B. Kanner

DOI: https://doi.org/10.1158/1535-7163.22499760.v1

2023-01-01

Abstract:Supplementary Figure Legends - PDF file 41K, Legends for supplemental figures 1-4
Supplementary Figures and Tables from Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER

Jeff Hsu,Colin Chong,Jeffrey Serrill,Levina Goon,Joan Balayan,Eric N. Johnson,Grachelle Lorenzana,Sharon Wu,Kevin G. Leong,Theodore J. Yun,Yong Wang,Faming Jiang,Lynne Bannen,Peter Lamb,Wei Xu,Peiwen Yu

DOI: https://doi.org/10.1158/1535-7163.22523460

2023-01-01

Abstract:Supplementary Figures and Tables with adjoining Legends
Supplementary Figure Legends 1-10 from Proteasome Inhibition Causes Regression of Leukemia and Abrogates BCR-ABL–Induced Evasion of Apoptosis in Part Through Regulation of Forkhead Tumor Suppressors

Zainab Jagani,Keli Song,Jeffery L. Kutok,M. Rajan Dewar,Armelle Melet,Tanya Santos,Alexandra R. Grassian,Saghi Ghaffari,Catherine J. Wu,Ruibao Ren,Heather Yeckes Rodin,Kenneth G. Miller,Roya Khosravi‐Far

DOI: https://doi.org/10.1158/0008-5472.22378412

2023-01-01

Abstract:Supplementary Figure Legends 1-10 from Proteasome Inhibition Causes Regression of Leukemia and Abrogates BCR-ABL–Induced Evasion of Apoptosis in Part through Regulation of Forkhead Tumor Suppressors
Supplementary Figure Legends 1-4 from The Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and Apoptosis to Suppress Liver Cancer Cell Growth

Zhongguang Luo,Guangyang Yu,Hyuk Woo Lee,Lihui Li,Lingyan Wang,Dongqin Yang,Yongfu Pan,Chan Ding,Jing Qian,Lijun Wu,Yiwei Chu,Jing Yi,Xiangdong Wang,Yi Sun,Lak Shin Jeong,Jie Liu,Lijun Jia

DOI: https://doi.org/10.1158/0008-5472.22393787

2023-01-01

Abstract:PDF file - 94K
Supplementary Figure Legends from RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer

Yajing Liu,Monika L. Burness,Rachel Martin-Trevino,Joey Guy,Shoumei Bai,Ramdane Harouaka,Michael Brooks,Shang Li,Alex Fox,Tahra Luther,April Davis,Trenton L. Baker,Justin A. Colacino,Shawn G. Clouthier,Zhi‐Ming Shao,Max S. Wicha,Suling Liu

DOI: https://doi.org/10.1158/1078-0432.22460774.v1

2023-01-01

Abstract:Supplementary figures 1-8 legends
Supplementary Figure Legends and References from LIMD2 Is a Small LIM-Only Protein Overexpressed in Metastatic Lesions That Regulates Cell Motility and Tumor Progression by Directly Binding to and Activating the Integrin-Linked Kinase

Hongzhuang Peng,Mehdi Talebzadeh-Farrooji,Michael J. Osborne,Jeremy W. Prokop,Paul C. McDonald,Jayashree Karar,Zhaoyuan Hou,Mei He,Electron Kebebew,Torben Orntoft,Meenhard Herlyn,Andrew J. Caton,William Fredericks,Bruce Malkowicz,Christopher S. Paterno,Alexandra S. Carolin,David W. Speicher,Emmanuel Skordalakes,Qihong Huang,Shoukat Dedhar,Katherine L.B. Borden,Frank J. Rauscher

DOI: https://doi.org/10.1158/0008-5472.22401231

2023-01-01

Abstract:Legend for Supplementary Figures S1-S6. Also includes Supplementary References.
Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Hangyi H. Yan,Jiang Jian,Yanli Pang,B.R. Achyut,Michael M. Lizardo,Xinhua Liu,Kent W. Hunter,Chand Khanna,Christine M. Hollander,Li Yang

DOI: https://doi.org/10.1158/0008-5472.22407863

2023-01-01

Abstract:Legend for Supplementary Figures S1-S6.
Supplementary Figure Legends from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Tingyu Wu,Wei Chen,Yongwang Zhong,Xiaodan Hou,Shengyun Fang,Chen-Ying Liu,Guanghui Wang,Tong Yu,Yu-Yang Huang,Xuesong Ouyang,Henry Q.X. Li,Long Cui,Yili Yang

DOI: https://doi.org/10.1158/1535-7163.22507968.v1

2023-01-01

Abstract:Bortezomib and KPT330 co-treatment inhibit patients-derived xenografts in nude mice.
Supplementary Figure Legends from Accelerated Tumor Growth Mediated by Sublytic Levels of Antibody-Induced Complement Activation is Associated with Activation of the PI3K/AKT Survival Pathway

Xiaohong Wu,Govind Ragupathi,Katherine S. Panageas,Feng Hong,Philip O. Livingston

DOI: https://doi.org/10.1158/1078-0432.22446662

2023-01-01

Abstract:Legend for supplementary figures - PDF file 62K, Supplementary Figure Legend
Supplemental Figure Legends from Expression of GRP78, Master Regulator of the Unfolded Protein Response, Increases Chemoresistance in Pancreatic Ductal Adenocarcinoma

Jenifer B. Gifford,Wei Huang,Ann E. Zeleniak,Antreas Hindoyan,Hong Wu,Timothy R. Donahue,Reginald Hill

DOI: https://doi.org/10.1158/1535-7163.22508517

2023-01-01

Abstract:Figure legends for the supplemental table and each of the supplemental figures.
Supplementary Figure and Table Legends from NF1 Inactivation in Adult Acute Myelogenous Leukemia

Brian Parkin,Peter Ouillette,Yin Wang,Yan Liu,Whitney Wright,Diane Roulston,Anjali Purkayastha,Amanda Dressel,Judith Karp,Paula Bockenstedt,Ammar Al-Zoubi,Moshe Talpaz,Lisa Kujawski,Yang Liu,Kerby Shedden,Sajid Shakhan,Cheng Li,Harry Erba,Sami N. Malek

DOI: https://doi.org/10.1158/1078-0432.22442919

2023-01-01

Abstract:Supplementary Figure and Table Legends from NF1 Inactivation in Adult Acute Myelogenous Leukemia
Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced let-7g Expression in Breast Cancer Invasion and Metastasis

Pengxu Qian,Zehua Zuo,Zhengsheng Wu,Xianyi Meng,Gaopeng Li,Zhengzhou Wu,Weijie Zhang,Sheng Tan,Vijay Pandey,Yandan Yao,Puyue Wang,Liqing Zhao,Jun Wang,Qiang Wu,Erwei Song,Peter E. Lobie,Zhinan Yin,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.22391054

2023-01-01

Abstract:PDF file - 214K
Supplemental Figure Legends from Notch Pathway Inhibition Using PF-03084014, a Γ-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer

Di Cui,Jinlu Dai,Jill M. Keller,Atsushi Mizokami,Shujie Xia,Evan T. Keller

DOI: https://doi.org/10.1158/1078-0432.22460979.v1

2023-01-01

Abstract:Supplemental Figure Legends
Supplemental Figure Legends from Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors

Enxiu Wang,Liang-Chuan Wang,Ching-Yi Tsai,Vijay Bhoj,Zack Gershenson,Edmund K. Moon,Kheng Newick,Jing Sun,Albert Lo,Timothy Baradet,Michael D. Feldman,David M. Barrett,Ellen Puré,Steven Μ. Albelda,Michael C. Milone

DOI: https://doi.org/10.1158/2326-6066.22538600.v1

2023-01-01

Abstract:Figure legends for supplemental data.

Supplementary Figure Legend from Small-Molecule Inhibitors of USP1 Target ID1 Degradation in Leukemic Cells

Supplementary Figure Legends from Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells

Supplementary Figure Legend from Synergistic Activities of MET/RON Inhibitor BMS-777607 and Mtor Inhibitor AZD8055 to Polyploid Cells Derived from Pancreatic Cancer and Cancer Stem Cells

Supplementary Figure Legends and Supplementary Figures 1 Through 4 from A Novel Therapeutic Strategy to Rescue the Immune Effector Function of Proteolytically Inactivated Cancer Therapeutic Antibodies

Supplementary Figure 3 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Supplementary Figure 1 from Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Supplementary Methods and Figure Legends from USP22 Deubiquitinates CD274 to Suppress Anticancer Immunity

Supplementary Figure Legends from Pharmacologic Activation of PKM2 Slows Lung Tumor Xenograft Growth

Supplementary Figures and Tables from Preclinical Characterization of XL092, a Novel Receptor Tyrosine Kinase Inhibitor of MET, VEGFR2, AXL, and MER

Supplementary Figure Legends 1-10 from Proteasome Inhibition Causes Regression of Leukemia and Abrogates BCR-ABL–Induced Evasion of Apoptosis in Part Through Regulation of Forkhead Tumor Suppressors

Supplementary Figure Legends 1-4 from The Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and Apoptosis to Suppress Liver Cancer Cell Growth

Supplementary Figure Legends from RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer

Supplementary Figure Legends and References from LIMD2 Is a Small LIM-Only Protein Overexpressed in Metastatic Lesions That Regulates Cell Motility and Tumor Progression by Directly Binding to and Activating the Integrin-Linked Kinase

Supplementary Figure Legend from CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ

Supplementary Figure Legends from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Supplementary Figure Legends from Accelerated Tumor Growth Mediated by Sublytic Levels of Antibody-Induced Complement Activation is Associated with Activation of the PI3K/AKT Survival Pathway

Supplemental Figure Legends from Expression of GRP78, Master Regulator of the Unfolded Protein Response, Increases Chemoresistance in Pancreatic Ductal Adenocarcinoma

Supplementary Figure and Table Legends from NF1 Inactivation in Adult Acute Myelogenous Leukemia

Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced &lt;i&gt;let-7g&lt;/i&gt; Expression in Breast Cancer Invasion and Metastasis

Supplemental Figure Legends from Notch Pathway Inhibition Using PF-03084014, a Γ-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer

Supplemental Figure Legends from Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors

Supplementary Figure Legends 1-6, Methods from Pivotal Role of Reduced <i>let-7g</i> Expression in Breast Cancer Invasion and Metastasis